Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?

被引:42
|
作者
Nguyen, T. N. [1 ,2 ,3 ,4 ]
Cumming, R. G. [4 ]
Hilmer, S. N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW 2006, Australia
[2] Univ Sydney, Royal N Shore Hosp, Dept Aged Care, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[4] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
关键词
atrial fibrillation; frailty; anticoagulant; anti-arrhythmic; stroke; bleeding; ANTICOAGULATION THERAPY; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; MAJOR HEMORRHAGE; HEART-FAILURE; HIGH-RISK; WARFARIN; STROKE; DIGOXIN; IMPACT;
D O I
10.1111/imj.12912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundFrailty is common in patients with atrial fibrillation and may impact on antithrombotic and anti-arrhythmic treatment. AimTo describe differences in clinical characteristics, prescription of antithrombotic and anti-arrhythmic medications and incidence of haemorrhage and stroke, between frail and non-frail older inpatients. MethodsProspective observational study in patients aged 65years with atrial fibrillation admitted to a teaching hospital in Sydney, Australia. Frailty was assessed using the Reported Edmonton Frail Scale, stroke risk with CHA2DS2-VASc score and bleeding risk with HAS-BLED score. Participants were followed after 6months for haemorrhages and strokes. ResultsWe recruited 302 patients (mean age 84.7 7.1years, 53.3% frail, 50% female, mean CHA2DS2-VASc 4.61 +/- 1.44, mean HAS-BLED 2.97 +/- 1.04). Frail participants were older and had more co-morbidities and higher risk of stroke but not haemorrhage. Upon discharge, 55.7% participants were prescribed with anticoagulants (49.3% frail, 62.6% non-frail, P = 0.02). Thirty-three per cent received antiplatelets only and 11.1% no antithrombotics, with no difference by frailty status. For anti-arrhythmics, 52.6% received rate-control drugs only, 11.8% rhythm-control drugs only and 13.5% both and 22.1% were not prescribed either, with no difference by frailty status. On univariate logistic regression, frailty decreased the likelihood of anticoagulant prescription (odds ratio (OR) 0.58, 95%CI 0.36-0.93), but this was not significant on multivariate analysis (OR 0.66, 95%CI 0.40-1.11). After 6months, overall incidence of ischaemic stroke was 2.1%, and in patients taking anticoagulants, incidence of major/severe bleeding was 6.3%, with no significant difference between frailty groups. ConclusionsFrailty status had little impact on antithrombotic prescription and no impact on anti-arrhythmic prescription.
引用
收藏
页码:86 / 95
页数:10
相关论文
共 47 条
  • [21] Dose-Response Relationships between Diet Quality and Mortality among Frail and Non-Frail Older Adults: A Population-Based Kyoto-Kameoka Prospective Cohort Study
    Daiki Watanabe
    T. Yoshida
    H. Nanri
    Y. Watanabe
    A. Itoi
    C. Goto
    K. Ishikawa-Takata
    Y. Yamada
    H. Fujita
    M. Miyachi
    M. Kimura
    The journal of nutrition, health & aging, 2023, 27 : 1228 - 1237
  • [22] PROCEDURAL AND IN-HOSPITAL COMPLICATIONS, TIME FROM PRESENTATION TO INVASIVE TREATMENT AND LENGTH OF HOSPITAL STAY IN FRAIL VERSUS NON-FRAIL OLDER (≥75 YEARS) PATIENTS WITH NON ST ELEVATION ACUTE CORONARY SYNDROME
    Veerasamy, Murugapathy
    Sinclair, Hannah
    Qiu, Weiliang
    Kunadian, Vijayalakshmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A89 - A89
  • [23] Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan
    Peng, Tao-Chun
    Chen, Wei-Liang
    Chen, Yuan-Yuei
    Chao, Yuan-Ping
    Wu, Li-Wei
    Kao, Tung-Wei
    BRITISH JOURNAL OF NUTRITION, 2021, 126 (11) : 1749 - 1757
  • [24] Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
    Millis, Christopher E.
    Feradov, Denise F.
    Prida, Xavier E.
    CIRCULATION, 2024, 150 (02) : e23 - e24
  • [25] Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
    Joosten, Linda P. T.
    van Doorn, Sander
    van de Ven, Peter M.
    Kohlen, Bart T. G.
    Nierman, Melchior C.
    Koek, Huiberdina L.
    Hemels, Martin E. W.
    Huisman, Menno V.
    Kruip, Marieke
    Faber, Laura M.
    Wiersma, Nynke M.
    Buding, Wim F.
    Fijnheer, Rob
    Adriaansen, Henk J.
    Roes, Kit C.
    Hoes, Arno W.
    Rutten, Frans H.
    Geersing, Geert-Jan
    CIRCULATION, 2024, 149 (04) : 279 - 289
  • [26] Home and clinical assessments of instrumental activities of daily living: what could explain the difference between settings in frail older adults, if any?
    Provencher, Veronique
    Demers, Louise
    Gelinas, Isabelle
    BRITISH JOURNAL OF OCCUPATIONAL THERAPY, 2009, 72 (08) : 339 - 348
  • [27] Observational Study of Curative Effects Between Complete Video-Assisted Thoracoscopic Surgery and Conservative Treatment for Multiple Rib Fractures in Non-Frail Chests
    Han, Minghui
    Zhang, Qingying
    Xue, Gang
    Yang, Jing
    Liu, Tianyuan
    Gao, Yuanqing
    Zhao, Hong
    Yang, Ronghua
    WORLD JOURNAL OF SURGERY, 2025,
  • [28] MAJOR ADVERSE CARDIOVASCULAR EVENTS AT 30-DAYS WERE NOT SIGNIFICANTLY DIFFERENT BETWEEN FRAIL AND NON-FRAIL OLDER (≥75 YEARS) PATIENTS WITH NON ST ELEVATION ACUTE CORONARY SYNDROME MANAGED BY INVASIVE STRATEGY: AN ANALYSIS FROM THE ICON1 STUDY
    Kunadian, Vijay
    Veerasamy, Murugapathy
    Sinclair, Hannah
    Qiu, Weiliang
    Das, Rajiv
    Ahmed, Javed
    Purcell, Ian
    Edwards, Richard
    Zaman, Azfar
    Bagnall, Alan
    HEART, 2015, 101 : A3 - A4
  • [29] Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation
    Trani, Antonio
    Benedetto, Pietro
    Di Leo, Ferdinando
    Baiano, Angela
    Esposito, Andrea
    Menna, Danilo
    Allegretti, Arianna
    Cappiello, Pierluigi Antonino
    Dell'Edera, Domenico
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2020, 6 (01)
  • [30] Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation
    Antonio Trani
    Pietro Benedetto
    Ferdinando Di Leo
    Angela Baiano
    Andrea Esposito
    Danilo Menna
    Arianna Allegretti
    Pierluigi Antonino Cappiello
    Domenico Dell’Edera
    Journal of Pharmaceutical Health Care and Sciences, 6